Ongoing Research Grants
Iketani Foundation for Science and Technology | JPY 3.0 million | June 2026–May 2028
Development of a PSMA-Targeted Tumor Vasculature Drug Discovery Platform through Medical–Engineering Collaboration
Project Mirai | JPY 1.0 million | January 2026–December 2026
Implementation of Innovative Genomic Medicine through Single-Cell Analysis of Japanese Prostate Cancer PDX and Organoid Models
The Hitachi Global Foundation, Kurata Grants | JPY 1.0 million | January 2026–December 2026
Molecular Basis and Therapeutic Targeting of PSMA-Positive Tumor Vasculature toward a Tumor-Agnostic Treatment Strategy
Takeda Science Foundation (Continuing Grant) | JPY 2.0 million | April 2025–March 2029
Genomic Analysis of Prostate Cancer with Pathological Features of Intraductal Carcinoma of the Prostate (IDC-P) and Its Application to Precision Medicine
Kobayashi Foundation for Cancer Research | JPY 5.0 million | June 2025–May 2026
Elucidation of the Mechanisms of Neuroendocrine Prostate Cancer and Development of Novel Therapies through Integrated Single-Cell and Spatial Transcriptomic Analysis of PDX Models
Yamaguchi Endocrine Research Foundation | JPY 2.5 million | April 2025–March 2026
Elucidation of AR-V7 Activation Mechanisms Using a Wheat Cell-Free Protein Synthesis System and Development of Novel Therapeutics for Hormone-Resistant Prostate Cancer
Takahashi Industrial and Economic Research Foundation | JPY 3.0 million | April 2023–March 2026
Elucidation of Prostate Cancer Progression Using State-of-the-Art Single-Cell RNA Sequencing of FFPE Tissues and Its Application to Precision Medicine
Co-investigator / Collaborative Research
JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 3.0 million | April 2026–March 2029
Targeted Drug Treatment Strategies for Rare Prostatic Ductal Carcinoma Based on Spatial Transcriptomic Analysis
Co-Investigator (Principal Investigator: Hiroaki Kobayashi)
JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 3.0 million | April 2026–March 2029
Elucidation of the Spatial Molecular Basis of the Antiepileptic Effects of Valaciclovir
Co-Investigator (Principal Investigator: Kenji Takechi)
JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.55 million | April 2025–March 2028
Validation of Galectin-7 as a Diagnostic Marker and Therapeutic Target in Squamous Differentiation of Urothelial Carcinoma
Co-Investigator (Principal Investigator: Shunsuke Haga)
JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.68 million | April 2024–March 2027
Elucidation of the Pathogenesis of Intraductal Carcinoma of the Prostate through Single-Cell Analysis of Prostate Cancer Spheroids
Co-Investigator (Principal Investigator: Noriyoshi Miura)
Completed Research Grants
Kobayashi Foundation | JPY 3.5 million | April 2024–March 2026
Establishment of Asian Prostate Cancer Cell Lines and Elucidation of Mechanisms Underlying Resistance to Hormonal Therapy through Single-Cell Analysis
The Japan Endocrine Society, Young Investigator Research Grant | JPY 2.5 million | April 2025–March 2026
Development of Innovative AR-V7-Targeted Therapeutics for Hormone-Resistant Prostate Cancer Using a Wheat Cell-Free Protein Synthesis System
Nippon Shinyaku Research Grant | JPY 3.0 million | April 2025–March 2026
Elucidation of the Pathogenesis of Intraductal Carcinoma of the Prostate (IDC-P) Using Single-Cell Analysis of PDX Models and High-Resolution Spatial Transcriptomics
JSPS KAKENHI, Fund for the Promotion of Joint International Research (Fostering Joint International Research (B)) | JPY 20.0 million | October 2022–March 2026
International Collaborative Research to Identify Novel Driver Genes in Prostate Cancer through Single-Cell Analysis
Research Collaborator (Principal Investigator: Tadahiko Kikugawa)
JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.16 million | April 2022–March 2025
Regulatory Mechanisms of PSMA Expression and Its Molecular Functions in Renal Cancer-Associated Vascular Endothelial Cells
Co-Investigator (Principal Investigator: Tadahiko Kikugawa)
Suzuki Foundation for Urological Medicine | JPY 0.5 million | April 2024–March 2025
Elucidation of the Mechanisms Promoting PSMA-Positive Peritumoral Angiogenesis in Renal Cell Carcinoma Using Spatial Gene Expression Analysis and Development of Novel Therapeutic Strategies
Yasumoto Tokumori Memorial Foundation for Tuberous Sclerosis Complex | JPY 2.0 million | April 2024–March 2025
Spatial Gene Expression Analysis of Tuberous Sclerosis Complex-Associated Renal Angiomyolipoma
JSPS KAKENHI, Grant-in-Aid for Scientific Research (C) | JPY 4.17 million | April 2022–March 2025
Elucidation of Tumor Microenvironment-Mediated Mechanisms Underlying the Development of Neuroendocrine Prostate Cancer through Single-Cell Analysis
Takeda Science Foundation | JPY 2.0 million | April 2022–March 2025
Genomic Analysis of Prostate Cancer with Pathological Features of Intraductal Carcinoma of the Prostate (IDC-P) and Its Application to Precision Medicine
Life Science Foundation of Japan | JPY 1.0 million | April 2023–March 2025
Elucidation of the Mechanisms of Neuroendocrine Differentiation in Prostate Cancer Using State-of-the-Art Single-Cell RNA Sequencing and Its Application to Precision Medicine
Prostate Research Foundation | JPY 1.0 million | March 2023–March 2024
Elucidation of the Genetic Mechanisms Underlying the Progression of Intraductal Carcinoma of the Prostate (IDC-P) Using State-of-the-Art Single-Cell Analysis and Its Application to Precision Medicine
Japanese Urological Association Young Research Grant | JPY 0.5 million | March 2023–March 2024
Elucidation of Tumor Microenvironment-Mediated Mechanisms Underlying the Progression of Intraductal Carcinoma of the Prostate (IDC-P) Using Single-Cell Technologies and Its Application to Precision Medicine
SGH Foundation | JPY 1.0 million | December 2022–December 2023
Elucidation of the Mechanisms of Neuroendocrine Prostate Cancer Differentiation and Development of Novel Therapies Using Single-Cell Analysis
Kowa Life Science Foundation | JPY 1.0 million | December 2022–December 2023
Single-Cell Analysis of Neuroendocrine Differentiation in Prostate Cancer Cell Lines
JSPS KAKENHI, Grant-in-Aid for Early-Career Scientists | JPY 4.29 million | April 2020–March 2022
Analysis of the Protein Degradation Mechanism of the Prostate Cancer Driver Gene ETV1 and Its Application to Prostate Cancer Therapy